All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH insulin to insulin glargine: The COBIN2 study

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F14%3A10271978" target="_blank" >RIV/00064203:_____/14:10271978 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216208:11130/14:10271978 RIV/00216208:11140/14:10271978 RIV/00669806:_____/14:10271978

  • Result on the web

    <a href="http://dx.doi.org/10.1007/s00508-014-0508-6" target="_blank" >http://dx.doi.org/10.1007/s00508-014-0508-6</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1007/s00508-014-0508-6" target="_blank" >10.1007/s00508-014-0508-6</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Comparison of glucose variability assessed by a continuous glucose-monitoring system in patients with type 2 diabetes mellitus switched from NPH insulin to insulin glargine: The COBIN2 study

  • Original language description

    Glucose variability combined with glycosylated hemoglobin (HbA1c) assessments more reliably represents the level of glycemic control. The study was aimed to compare blood glucose variability with insulin glargine vs. neutral protamine Hagedorn (NPH) in patients with type 2 diabetes mellitus using a continuous glucose-monitoring system (CGMS), in patients treated with basal insulin using stable dose of oral antidiabetic agents and HbA1c in the range of 4.5-8.0 % International Federation of Clinical Chemistry (IFCC) units. [6.2-9.4 % Diabetes Control and Complications Trial (DCCT) units]. This was a multicenter, prospective, open-label, single-arm study in patients (N = 116) treated for a parts per thousand yenaEuro parts per thousand 2 months with NPH and metformin combined with sulfonylurea or glinide. Glucose variability was measured after a 4-week NPH treatment phase and after a subsequent 12-week glargine treatment phase using CGMS. Based on 72-hour CGMS, glucose variability was ass

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)

  • CEP classification

    FB - Endocrinology, diabetology, metabolism, nutrition

  • OECD FORD branch

Result continuities

  • Project

  • Continuities

    I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2014

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Wiener Klinische Wochenschrift

  • ISSN

    0043-5325

  • e-ISSN

  • Volume of the periodical

    126

  • Issue of the periodical within the volume

    7-8

  • Country of publishing house

    AT - AUSTRIA

  • Number of pages

    10

  • Pages from-to

    228-237

  • UT code for WoS article

    000335170200008

  • EID of the result in the Scopus database